Landon Moyers
Psychiatric/Mental Health · Sandy, UTNPI 1811554751
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 306 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 306 payments — averaging $18.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Johnson & Johnson$1K
- Neurocrine Biosciences, Inc.$475
- Vanda Pharmaceuticals Inc.$474
- Teva Pharmaceuticals USA, Inc.$462
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$303
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,774100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $1,122 |
| Johnson & Johnson | 48 | $1,031 |
| Neurocrine Biosciences, Inc. | 20 | $475 |
| Vanda Pharmaceuticals Inc. | 14 | $474 |
| Teva Pharmaceuticals USA, Inc. | 33 | $462 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $303 |
| Lundbeck LLC | 17 | $303 |
| Otsuka America Pharmaceutical, Inc. | 16 | $291 |
| Axsome Therapeutics, Inc. | 12 | $226 |
| Eisai Inc. | 16 | $163 |
| Alkermes, Inc. | 8 | $161 |
| Ironshore Pharmaceuticals Inc. | 8 | $140 |
| Supernus Pharmaceuticals, Inc. | 17 | $135 |
| Idorsia Pharmaceuticals US Inc | 8 | $119 |
| Sunovion Pharmaceuticals Inc. | 5 | $83 |
| Tris Pharma Inc | 3 | $65 |
| Corium, LLC | 3 | $63 |
| Indivior Inc. | 2 | $38 |
| Tempus AI, Inc | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Biogen | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,782 in reported general payments places this provider in the 95th percentile of 393 psychiatric/mental health providers in Utah.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 11 | $2,187 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $632 |
| Alprazolam | 12 | $167 |
| Risperidone | 13 | $145 |
| Duloxetine Hcl | 11 | $88 |
| Metformin Hcl | 16 | $78 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Sandy
- Sumer AndersonSandy$8K
- Jennifer OlsenSandy$6K
- Kim McKinnonSandy$6K
- Kylee PulsipherSandy$5K
- Bret HafenLayton$381K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
- Debra HainRiverton$29K
- Kristin BarberSalt Lake City$28K
- Briana TerrySalt Lake City$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.